Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Karcinolys S.A.S.
DescriptionReplication-conditional oncolytic virus derived from herpes simplex virus type 1 (HSV-1) through targeted genetic engineering
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today